Drug Profile
Research programme: protein kinase TTK inhibitors - Netherlands Translational Research Center
Alternative Names: NTRC 00660; NTRC 1501-0Latest Information Update: 07 Sep 2023
Price :
$50
*
At a glance
- Originator Netherlands Translational Research Center
- Class Antineoplastics; Indolizines; Pyrimidines; Small molecules
- Mechanism of Action TTK protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 07 Sep 2023 Preclinical development is ongoing in Solid-tumours in Netherlands (PO) (Netherlands Translational Research Center website; September 2023)
- 28 May 2020 No recent reports of development identified for preclinical development in Solid-tumours in Netherlands (PO)
- 01 Apr 2017 Preclinical data in Cancer presented at the 108th Annual Meeting of the American Association for Cancer Research (AACR-2017)